Insider · CIK 0001334549
David J Mazzo
ceopresidentofficerdirector
Files at LSTA (LISATA THERAPEUTICS, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 9, 2025 | LSTA LISATA THERAPEUTICS, INC. | AGrant or award Common Stock | +81,000 | $0.00 | $0 | 295,152 | Jan 13, 2025 |
| Jan 9, 2025 | LSTA LISATA THERAPEUTICS, INC. | FTax withholding Common Stock | -9,414 | $3.80 | $36k | 285,738 | Jan 13, 2025 |
| Jan 9, 2025 | LSTA LISATA THERAPEUTICS, INC. | FTax withholding Common Stock | -10,925 | $3.80 | $42k | 274,813 | Jan 13, 2025 |
| Jan 9, 2025 | LSTA LISATA THERAPEUTICS, INC. | FTax withholding Common Stock | -7,017 | $3.80 | $27k | 267,796 | Jan 13, 2025 |
| Jan 10, 2025 | LSTA LISATA THERAPEUTICS, INC. | FTax withholding Common Stock | -3,106 | $3.73 | $12k | 264,690 | Jan 13, 2025 |
| Jan 9, 2025 | LSTA LISATA THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jan 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.